[Mitochondrial cardiomyopathy].
作者信息
Tanaka Masashi
机构信息
Department of Gene Therapy, Gifu International Institute of Biotechnology.
出版信息
Nihon Rinsho. 2002 Apr;60 Suppl 4:306-11.
PMID:12013873
Abstract
摘要
相似文献
1
[Mitochondrial cardiomyopathy].
Nihon Rinsho. 2002 Apr;60 Suppl 4:306-11.
2
Mitochondrial cardiomyopathy: molecular and biochemical analysis.
Pediatr Cardiol. 1997 Jul-Aug;18(4):251-60. doi: 10.1007/s002469900169.
3
Mitochondrial A3243G mutation with manifestation of acute dilated cardiomyopathy.
Circ Heart Fail. 2012 Jan;5(1):e1-3. doi: 10.1161/CIRCHEARTFAILURE.111.963900.
4
[Pure mitochondrial myopathy].
Nihon Rinsho. 2002 Apr;60 Suppl 4:302-5.
5
[Diagnosis of mitochondrial cardiomyopathies: the need for a multidisciplinary approach].
G Ital Cardiol. 1999 Oct;29(10):1181-3.
6
Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
J Cardiovasc Pharmacol. 2003 Jan;41 Suppl 1:S5-10.
7
Are Angiotensin-converting enzyme inhibitors and beta-blockers ineffective in children with dilated cardiomyopathy and heart failure?
J Am Coll Cardiol. 2010 Aug 31;56(10):823; author reply 823-4. doi: 10.1016/j.jacc.2010.04.037.
8
[Progress in the treatment of myocardial diseases].
Nihon Naika Gakkai Zasshi. 1990 Mar 10;79(3):363-6.
9
Current management of pediatric dilated cardiomyopathy.
Curr Opin Cardiol. 2010 Mar;25(2):80-7. doi: 10.1097/HCO.0b013e328335b220.
10
Up to date in pharmacological treatment of dilated cardiomyopathy.
Rom J Intern Med. 2004;42(1):3-13.
Zotero 插件